LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,533,351 | +27.5% | 21,267 | +30.1% | 0.04% | +21.2% |
| Q1 2023 | $1,202,780 | -23.5% | 16,351 | -30.5% | 0.03% | -26.7% |
| Q4 2022 | $1,571,737 | +16.0% | 23,529 | +49.5% | 0.04% | -6.2% |
| Q3 2022 | $1,355,000 | +224.9% | 15,734 | +236.6% | 0.05% | +152.6% |
| Q2 2022 | $417,000 | -26.6% | 4,674 | +27.0% | 0.02% | -45.7% |
| Q4 2021 | $568,000 | -9.8% | 3,680 | -44.3% | 0.04% | -14.6% |
| Q3 2020 | $630,000 | +2.4% | 6,611 | +20.2% | 0.04% | -4.7% |
| Q2 2020 | $615,000 | -30.7% | 5,502 | -54.9% | 0.04% | -32.8% |
| Q1 2020 | $888,000 | +168.3% | 12,205 | +267.2% | 0.06% | +120.7% |
| Q3 2019 | $331,000 | -29.4% | 3,324 | -19.0% | 0.03% | -31.0% |
| Q2 2019 | $469,000 | -87.2% | 4,106 | -84.8% | 0.04% | -81.7% |
| Q4 2018 | $3,662,000 | +131.0% | 26,987 | +367.5% | 0.23% | +92.4% |
| Q3 2018 | $1,585,000 | +189.8% | 5,773 | -18.7% | 0.12% | +112.5% |
| Q1 2015 | $547,000 | -0.9% | 7,100 | -31.7% | 0.06% | -42.9% |
| Q4 2014 | $552,000 | – | 10,392 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |